Catalyst Wire Dossier Catalyst Wire Dossier

IOPIDINE 1%

APRACLONIDINE HYDROCHLORIDE OPHTHALMIC SOLUTION · Harrow Eye, LLC
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for IOPIDINE 1%, covering 2015-11-05 to 2026-03-18. Get the full timeline:

Most recent: FDA Approved: IOPIDINE 1% — Supplemental Application (Harrow Eye, LLC)

See pricing